» Articles » PMID: 26676659

Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy

Overview
Journal Rev Diabet Stud
Specialty Endocrinology
Date 2015 Dec 18
PMID 26676659
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

This article reviews the impact of diabetes and its treatment on vascular function with a focus on the reactivity of epineurial arterioles, blood vessels that provide circulation to the sciatic nerve. Another focus is the relationship between the dysregulation of neurovascular function and diabetic peripheral neuropathy. Diabetic peripheral neuropathy is a debilitating disorder that occurs in more than 50 percent of patients with diabetes. The etiology involves metabolic, vascular, and immunologic pathways besides neurohormonal growth factor deficiency and extracellular matrix remodeling. In the light of this complex etiology, an effective treatment for diabetic peripheral neuropathy has not yet been identified. Current opinion postulates that any effective treatment for diabetic peripheral neuropathy will require a combination of life style and therapeutic interventions. However, a more comprehensive understanding of the factors contributing to neurovascular and neural dysfunction in diabetes is needed before such a treatment strategy can be developed. After reading this review, the reader should have gained insight into the complex regulation of vascular function and blood flow to the sciatic nerve, and the impact of diabetes on numerous elements of vascular reactivity of epineurial arterioles of the sciatic nerve.

Citing Articles

Role of TRPA1 in Painful Cold Hypersensitivity.

Nakagawa T, Kaneko S Adv Exp Med Biol. 2024; 1461:245-252.

PMID: 39289286 DOI: 10.1007/978-981-97-4584-5_17.


New perspectives in diabetic neuropathy.

Eid S, Rumora A, Beirowski B, Bennett D, Hur J, Savelieff M Neuron. 2023; 111(17):2623-2641.

PMID: 37263266 PMC: 10525009. DOI: 10.1016/j.neuron.2023.05.003.


Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia.

Miyashita A, Kobayashi M, Yokota T, Zochodne D Int J Mol Sci. 2023; 24(6).

PMID: 36983051 PMC: 10051459. DOI: 10.3390/ijms24065977.


Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?.

Al-Bazz D, Nelson A, Burgess J, Petropoulos I, Nizza J, Marshall A Diagnostics (Basel). 2022; 12(3).

PMID: 35328284 PMC: 8947384. DOI: 10.3390/diagnostics12030731.


Painful diabetic neuropathy leads to functional Ca3.2 expression and spontaneous activity in skin nociceptors of mice.

Hoffmann T, Kistner K, Joksimovic S, Todorovic S, Reeh P, Sauer S Exp Neurol. 2021; 346:113838.

PMID: 34450183 PMC: 8549116. DOI: 10.1016/j.expneurol.2021.113838.


References
1.
Yamagishi S, Nakamura K, Imaizumi T . Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2008; 1(1):93-106. DOI: 10.2174/1573399052952631. View

2.
Vatter H, Schilling L, Schmiedek P, Ehrenreich H . Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors. J Cardiovasc Pharmacol. 1998; 31 Suppl 1:S64-7. DOI: 10.1097/00005344-199800001-00021. View

3.
Nakamura J, Hamada Y, Chaya S, Nakashima E, Naruse K, Kato K . Transition metals and polyol pathway in the development of diabetic neuropathy in rats. Diabetes Metab Res Rev. 2002; 18(5):395-402. DOI: 10.1002/dmrr.319. View

4.
NUKADA H, Dyck P . Microsphere embolization of nerve capillaries and fiber degeneration. Am J Pathol. 1984; 115(2):275-87. PMC: 1900501. View

5.
Munzel T, Keaney Jr J . Are ACE inhibitors a "magic bullet" against oxidative stress?. Circulation. 2001; 104(13):1571-4. DOI: 10.1161/hc3801.095585. View